CAPITOL HILL STRATEGIES, LLC for MERCK & CO., INC
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R. 2021, Investing for the People Act of 2019, budget legislation, potential provisions relating to prescription drug pricing, reporting and oversight. H.R. 2113, the Prescription Drug Sunshine, Transparency, Accountability and Reporting Act or Prescription Drug STAR Act, provisions relating to prescription drug pricing, reporting and oversight requirements. H.R. 938, the Bringing Low-cost Options and Competition while Keeping Incentives for New Generics (BLOCKING) Act of 2019, provisions relating to patent exclusivity. H.R. 1520, the Purple Book Continuity Act of 2019, provisions that would codify publication of the patents of approved biological products in the Purple Book in a similar format and with similar requirements to the Orange Book H.R. 1503, the Orange Book Transparency Act of 2019, provisions to ensure that the Orange Book is accurate and up-to-date H.R. 965, the Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2019, provisions that would establish a process by which generic manufacturers could obtain sufficient quantities of brand drug samples for testing H.R. 269, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019, vaccines and other various provisions.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHARLES M BRAIN | Special Assistant to the President, Deputy Chief of Staff House Ways and Means Committee |
| A. J. WOJCIAK | Senior Legislative Aide, Rep. Earl Pomeroy |
Medicare/Medicaid MMM
H.R. 1046, Medicare Negotiation and Competitive Licensing Act of 2019, provisions relating to prescription drug pricing and intellectual property rights.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHARLES M BRAIN | Special Assistant to the President, Deputy Chief of Staff House Ways & Means Committee |
| A. J. WOJCIAK | Senior Legislative Aide to Rep. Earl Pomeroy |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.